FCDGC: MAN2A2 Enzyme Variant Causes New Type of Congenital Disorder of Glycosylation
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
5 de dic. de 2022 ·
1m 56s
New research from the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC). This summary is based on a paper published in the Journal of Medical Genetics on November 10, 2022,...
mostra más
New research from the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC). This summary is based on a paper published in the Journal of Medical Genetics on November 10, 2022, titled "Homozygous truncating variant in MAN2A2 causes a novel congenital disorder of glycosylation with neurological involvement."
Read the paper here: https://jmg.bmj.com/content/early/2022/11/10/jmg-2022-108821
Learn more about FCDGC: https://www.rarediseasesnetwork.org/fcdgc
mostra menos
Read the paper here: https://jmg.bmj.com/content/early/2022/11/10/jmg-2022-108821
Learn more about FCDGC: https://www.rarediseasesnetwork.org/fcdgc
Información
| Autor | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
